CN Patent

CN113666923A — 烷氧基烷基取代杂环基类抑制剂及其制备方法和应用

Assigned to Suzhou Zelgen Biopharmaceutical Co Ltd · Expires 2021-11-19 · 4y expired

What this patent protects

本发明涉及烷氧基烷基取代杂环基类抑制剂及其制备方法和应用。具体地，本发明化合物具有式(I)所示结构，本发明还公开了所述化合物的制备方法及其作为KRAS G12C 抑制剂的用途，对KRAS G12C 具有很好的选择性抑制作用且具有更好的药效学、药代动力学性能和更低的毒副作用。

USPTO Abstract

本发明涉及烷氧基烷基取代杂环基类抑制剂及其制备方法和应用。具体地，本发明化合物具有式(I)所示结构，本发明还公开了所述化合物的制备方法及其作为KRAS G12C 抑制剂的用途，对KRAS G12C 具有很好的选择性抑制作用且具有更好的药效学、药代动力学性能和更低的毒副作用。

Drugs covered by this patent

Patent Metadata

Patent number
CN113666923A
Jurisdiction
CN
Classification
—
Expires
2021-11-19
Drug substance claim
No
Drug product claim
No
Assignee
Suzhou Zelgen Biopharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.